ArticleScientific reports2026

The KRT15 and KRT81 complex promotes lenvatinib resistance in thyroid cancer by upregulating DGKB mediated lipid metabolism.

Yunjun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.